Coronavac
- All
- News
-
China's Sinovac Covid Booster Weaker Against Omicron, Hong Kong Study Shows
Three doses of Sinovac's CoronaVac COVID-19 vaccine do not produce adequate levels of antibodies to fight the Omicron variant of the coronavirus, researchers from Hong Kong said in a statement.
-
Chinese Covid Vaccine Safe, Effective In Children, Adolescents: Lancet Study
Two doses of the China-made COVID-19 vaccine, CoronaVac, are safe and produce a strong antibody response among children and adolescents aged 3-17 years, according to a study published in The Lancet Infectious Diseases journal.
-
China Authorises CoronaVac COVID-19 Vaccine For Children Above 3 Years
China has authorised the emergency use of CoronaVac, a COVID-19 vaccine manufactured by Chinese firm Sinovac, for children aged between 3 and 17 years, Sinovac Chairman Yin Weidong said.
-
China's Coronavac 80% Effective At Preventing Covid Deaths: Chile Results
China's Coronavac vaccine was 67 percent effective at preventing symptomatic Covid-19 and 80 percent at preventing death, according to real-life results unveiled Friday from Chile's inoculation campaign.
-
China's CoronaVac May Be Ineffective Against Brazil Covid Variant: Study
Amid an aggressive spread of the new COVID-19 strain from the Amazon in Brazil, a recent preliminary study has provided evidence that China's CoronaVac, the country's principal vaccine, might prove ineffective against the coronavirus variant.
-
China's Coronavac Vaccine Shows 50% Efficacy In Brazil
The Chinese-developed Coronavac Covid-19 vaccine has demonstrated a 50 percent efficacy following tests in Brazil, the organization in charge of its production in the South American country said on Tuesday.
-
Ukraine To Buy 2 Million Doses Of China's CoronaVac Vaccine
Ukraine said Wednesday it agreed to purchase nearly two million doses of the Chinese-developed CoronaVac coronavirus jab, the post-Soviet country's first commercial contract to purchase a vaccine.
-
Turkey Says China's Sinovac Covid-19 Vaccine, CoronaVac, 91.25% Effective In Late Trials
Sinovac Covid-19 Vaccine: Turkish researchers said no major side-effects were seen during their trial, apart from one person who had an allergic reaction
-
Chinese Covid Vaccine "Reached Efficacy Threshold": Brazil Institute
Clinical trials of the CoronaVac coronavirus vaccine developed by Chinese laboratory Sinovac have "reached the efficacy threshold" demanded by the World Health Organization, the Brazilian institute charged with its production and distribution said on Wednesday.
-
China Covid Vaccine Induces Quick Immune Response Within 4 Weeks: Study
Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.
-
Brazil Suspends Trials Of Chinese Covid-19 Vaccine Due To "Adverse Incident"
Brazil's health regulator said Monday it had suspended clinical trials of a Chinese-developed Covid-19 vaccine after an "adverse incident" involving a volunteer recipient, a blow for one of the most advanced vaccine candidates.
-
Sinovac's Covid Vaccine Candidate Approved For Emergency Use In China: Report
Sinovac Biotech coronavirus vaccine candidate CoronaVac was approved in July for emergency use as part of a programme in China to vaccinate high-risk groups such as medical staff, a person familiar with the matter said.
-
China's Sinovac Covid Booster Weaker Against Omicron, Hong Kong Study Shows
Three doses of Sinovac's CoronaVac COVID-19 vaccine do not produce adequate levels of antibodies to fight the Omicron variant of the coronavirus, researchers from Hong Kong said in a statement.
-
Chinese Covid Vaccine Safe, Effective In Children, Adolescents: Lancet Study
Two doses of the China-made COVID-19 vaccine, CoronaVac, are safe and produce a strong antibody response among children and adolescents aged 3-17 years, according to a study published in The Lancet Infectious Diseases journal.
-
China Authorises CoronaVac COVID-19 Vaccine For Children Above 3 Years
China has authorised the emergency use of CoronaVac, a COVID-19 vaccine manufactured by Chinese firm Sinovac, for children aged between 3 and 17 years, Sinovac Chairman Yin Weidong said.
-
China's Coronavac 80% Effective At Preventing Covid Deaths: Chile Results
China's Coronavac vaccine was 67 percent effective at preventing symptomatic Covid-19 and 80 percent at preventing death, according to real-life results unveiled Friday from Chile's inoculation campaign.
-
China's CoronaVac May Be Ineffective Against Brazil Covid Variant: Study
Amid an aggressive spread of the new COVID-19 strain from the Amazon in Brazil, a recent preliminary study has provided evidence that China's CoronaVac, the country's principal vaccine, might prove ineffective against the coronavirus variant.
-
China's Coronavac Vaccine Shows 50% Efficacy In Brazil
The Chinese-developed Coronavac Covid-19 vaccine has demonstrated a 50 percent efficacy following tests in Brazil, the organization in charge of its production in the South American country said on Tuesday.
-
Ukraine To Buy 2 Million Doses Of China's CoronaVac Vaccine
Ukraine said Wednesday it agreed to purchase nearly two million doses of the Chinese-developed CoronaVac coronavirus jab, the post-Soviet country's first commercial contract to purchase a vaccine.
-
Turkey Says China's Sinovac Covid-19 Vaccine, CoronaVac, 91.25% Effective In Late Trials
Sinovac Covid-19 Vaccine: Turkish researchers said no major side-effects were seen during their trial, apart from one person who had an allergic reaction
-
Chinese Covid Vaccine "Reached Efficacy Threshold": Brazil Institute
Clinical trials of the CoronaVac coronavirus vaccine developed by Chinese laboratory Sinovac have "reached the efficacy threshold" demanded by the World Health Organization, the Brazilian institute charged with its production and distribution said on Wednesday.
-
China Covid Vaccine Induces Quick Immune Response Within 4 Weeks: Study
Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.
-
Brazil Suspends Trials Of Chinese Covid-19 Vaccine Due To "Adverse Incident"
Brazil's health regulator said Monday it had suspended clinical trials of a Chinese-developed Covid-19 vaccine after an "adverse incident" involving a volunteer recipient, a blow for one of the most advanced vaccine candidates.
-
Sinovac's Covid Vaccine Candidate Approved For Emergency Use In China: Report
Sinovac Biotech coronavirus vaccine candidate CoronaVac was approved in July for emergency use as part of a programme in China to vaccinate high-risk groups such as medical staff, a person familiar with the matter said.
